These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15860870)

  • 21. Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.
    Waddell T; Gollins S; Soe W; Valle J; Allen J; Bentley D; Morris J; Lloyd A; Swindell R; Taylor MB; Saunders MP
    Cancer Chemother Pharmacol; 2011 May; 67(5):1111-7. PubMed ID: 20676676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.
    Stathopoulos GP; Koutantos J; Lazaki H; Rigatos SK; Stathopoulos J; Deliconstantinos G
    Anticancer Res; 2007; 27(3B):1653-6. PubMed ID: 17595791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer.
    Ardavanis AS; Ioannidis GN; Orphanos GS; Rigatos GA
    Anticancer Res; 2006; 26(2B):1669-72. PubMed ID: 16619589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?
    Lin EH; Curley SA; Crane CC; Feig B; Skibber J; Delcos M; Vadhan SR; Morris J; Ayers GD; Ross A; Brown T; Rodriguez-Bigas MA; Janjan N
    Am J Clin Oncol; 2006 Jun; 29(3):232-9. PubMed ID: 16755175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.
    Dennie TW; Fleming RA; Bowen CJ; Dar MM; Alberti D; Oliver K; Loconte N; Mulkerin D; Holen KD
    Clin Colorectal Cancer; 2011 Mar; 10(1):57-62. PubMed ID: 21609937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis.
    Jhaveri KD; Flombaum C; Shah M; Latcha S
    J Oncol Pharm Pract; 2012 Mar; 18(1):140-7. PubMed ID: 22392964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.
    Venturini M; Paridaens R; Rossner D; Vaslamatzis MM; Nortier JW; Salzberg M; Rodrigues H; Bell R
    Oncology; 2007; 72(1-2):51-7. PubMed ID: 18004077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.
    McCollum AD; Wu B; Clark JW; Kulke MH; Enzinger PC; Ryan DP; Earle CC; Michelini A; Fuchs CS
    Am J Clin Oncol; 2006 Feb; 29(1):40-4. PubMed ID: 16462501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.
    Sehgal R; Lembersky BC; Rajasenan KK; Crandall TL; Balaban EP; Pinkerton RA; Kane P; Schmotzer A; Zeh H; Potter DM; Ramanathan RK
    Clin Colorectal Cancer; 2011 Jun; 10(2):117-20. PubMed ID: 21859564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.
    Karacetin D; Yalcin B; Okten B; Ozturk S; Maral O; Incekara O
    J BUON; 2009; 14(4):605-8. PubMed ID: 20148449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.
    Lorvidhaya V; Chitapanarux I; Phromratanapongse P; Kamnerdsupaphon P; Tharavichitkul E; Lertsanguansinchai P; Hsieh CY; Sukthomya V
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1271-5. PubMed ID: 20647708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer.
    Rischin D; Phillips KA; Friedlander M; Harnett P; Quinn M; Richardson G; Martin A
    Gynecol Oncol; 2004 May; 93(2):417-21. PubMed ID: 15099955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancer.
    Naeim A; Ward PR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Hecht JR
    J Geriatr Oncol; 2013 Oct; 4(4):302-9. PubMed ID: 24472472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer.
    Hyodo I; Shirao K; Doi T; Hatake K; Arai Y; Yamaguchi K; Tamura T; Takemiya S; Takiuchi H; Nakagawa K; Mishima H
    Jpn J Clin Oncol; 2006 Jul; 36(7):410-7. PubMed ID: 16825251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To widen the setting of cancer patients who could benefit from metronomic capecitabine.
    Nannini M; Nobili E; Di Cicilia R; Brandi G; Maleddu A; Pantaleo MA; Biasco G
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):189-93. PubMed ID: 19151974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer.
    Fedele P; Marino A; Orlando L; Schiavone P; Nacci A; Sponziello F; Rizzo P; Calvani N; Mazzoni E; Cinefra M; Cinieri S
    Eur J Cancer; 2012 Jan; 48(1):24-9. PubMed ID: 21775129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine for treatment of advanced hepatocellular carcinoma.
    von Delius S; Lersch C; Mayr M; Stock K; Schulte-Frohlinde E; Schmid RM; Eckel F
    Hepatogastroenterology; 2007 Dec; 54(80):2310-4. PubMed ID: 18265654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.
    Xiang XJ; Zhang L; Qiu F; Yu F; Zhan ZY; Feng M; Yan J; Zhao JG; Xiong JP
    Chemotherapy; 2012; 58(1):1-7. PubMed ID: 22310723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
    Otterson GA; Herndon JE; Watson D; Green MR; Kindler HL;
    Lung Cancer; 2004 May; 44(2):251-9. PubMed ID: 15084390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.